Adinazolam
Discover related
3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | DrugCentral | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | — | ||
| Also known as | deracyn | — | — | |
| Safety | ||||
| Dose · Oral | ||||
| Light | 5–15 mg | — | — | |
| Common | 15–30 mg | — | — | |
| Strong | 30–50 mg | — | — | |
| Duration | ||||
| Onset | 10–25 minutes | — | — | |
| Total | 2–5 hours | — | — | |
| After-effects | 1–16 hours | — | — | |
| Pharmacology | ||||
| Receptor activity | — | — | GABRDTSPO | |
| Half-life | — | Less than 3 hours. | — | |
TripSit summary
Benzodiazepine derivative that has some antidepressant properties. Never FDA approved, yet however has been sold as a research chemical.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.